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ABSTRACT 
There are abundant studies indicating that blocking gap junctions (GJs) containing connexin 
36 (Cx36) inhibit seizures. However, recent evidences demonstrate proconvulsant effect of 
such intervention. Electrical coupling between GABAergic interneurons in CA1 region of 
hippocampus is mediated through Cx36 GJs. We investigated effect of quinine, a specific 
blocker of Cx36, on the seizure severity and epileptogenesis in amygala kindling model of 
epilepsy in rats. Quinine (1, 50, 100, 500 and 2000 µM/rat) was injected directly into the CA1 
and kindled seizure parameters including behavioral seizure stage, duration of evoked af-
terdischarges, and duration of generalized seizures behavior were recorded 10 min afterward. 
Moreover, quinine (1, 30, and 100 µM/rat) was injected intra CA1 once daily during kindling 
development. At the doses used, quinine had no significant effect on amygdala-kindled sei-
zures. However, quinine 100 µM significantly accelerated kindling rate. Blockade of Cx36 
GJs coupling and consequent disruption of inhibitory transmission in GABAergic interneu-
rons in CA1 area seems to be responsible for the antiepileptogenic effect of quinine.  
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INTRODUCTION 
Epilepsy, which is characterized by re-
current seizures, is one of the most common 
neurological disorders in the world. Ab-
normal synchronization of neuronal dis-
charges plays critical role in seizures (Car-
len et al., 2000). Besides chemical synap-
ses, direct coupling via gap junction (GJ) 
channels provides a second major pathway 
contributing to pathologic neuronal syn-
chronous firing in various in vitro (Ross et 
al., 2000; Köhling et al., 2001; Traub et al., 
2001; Jahromi et al., 2002) and in vivo (Pe-
rez-Velazquez et al., 1994; Szente et al., 
2002; Traub et al., 2002; Gajda et al., 2003) 
seizure models. Each GJ channel consists of 
two hemichannels termed connexon, each 
of which is composed of six subunit pro-
teins called connexin (Cx). Progressive un-
derstanding of the role of GJs in neuronal 
synchronization and generation of epileptic 
discharges has led to the identification of 
Cxs as potential molecular targets for de-
velopment of antiepileptic drugs (Meldrum 
and Rogawski, 2007).  
Temporal lobe structures and notably 
hippocampus are among most susceptible 
regions involved in acquisition of epilepsies 
and therefore temporal lobe epilepsy is the 
most common form of epilepsy (Wiebe, 
2000). There is strong evidence that GJs 
play a role in the fast oscillations that pre-
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cede the onset of seizures discharges in the 
hippocampus (LeBeau et al., 2003; Traub et 
al., 2011). In CA1 subfield of the hippo-
campus, paravalbumin positive GABAergic 
interneurons form a vast dendrodendritic 
network, which is responsible for synchro-
nized oscillations in hippocampus and 
thereby promote inhibitory transmission 
(Fukuda and Kosaka, 2000). Morphological 
(Fukuda and Kosaka, 2000; Baude et al., 
2007) and electrophysiological (Venance et 
al., 2000) evidence indicate that electrical 
coupling between GABAergic interneurons 
in this region is mediated by Cx36. Hence, 
it might be anticipated that enhancement of 
Cx36 GJ communication (GJC) in this re-
gion can reinforce the inhibitory circuit and 
thereby limit neuronal hyperexcitability and 
propagation of abnormal discharges to the 
neighboring areas. This assumption is sup-
ported by the recent finding of Jacobson et 
al. (2010) that Cx36 knockout mice has a 
markedly lowered seizure threshold for 
generalized tonic-clonic seizures compared 
to wild type animals. Furthermore, pharma-
cologic blockade of Cx36 GJs induces an 
excitatory effect on seizure-like activity in 
rat cortical slices (Voss et al., 2009).  
Quinine, the old anti-malaria drug, is 
the only available specific blocker of Cx36 
(Srinivas et al., 2001), which is currently 
used as a pharmacologic tool in research on 
the function of Cx36 in seizures' mecha-
nisms. Quinine suppresses ictal epilepti-
form activity in vitro without decreasing 
neuronal excitability (Bikson et al., 2002). 
Quinine has anticonvulsive effect at the al-
ready active epileptic focus and suppresses 
seizure activity in rat neocortex in vivo 
(Gajda et al., 2005). It also decreases ampli-
tude and frequency of epileptiform spikes 
in penicillin model of epilepsy (Bostanci 
and Bagirici, 2007). Quinine protects mice 
and rats against PTZ-induced seizures 
(Nassiri-Asl et al., 2008, 2009). Moreover, 
quinine injection into the entorhinal cortex 
of seizing rats has diminished the frequency 
and amplitude of the discharges in the hip-
pocampus (Medina-Ceja and Ventura-
Mejía, 2010). In contrast, quinine has pro-
convulsant effect on rat cortical slices 
(Voss et al., 2009). Moreover, transgenic 
mice lacking Cx36 are seizure prone (Ja-
cobson et al., 2010). Cx36 blockade has 
been ineffective in reducing seizure-like 
activity in neocortical mouse slices (Voss et 
al., 2010b). In spite of these extensive in 
vitro and in vivo investigations, role of 
Cx36 containing GJs present in CA1 area of 
the hippocampus, in seizure initiation and 
development of epilepsy is not directly 
evaluated.  
In this study, we examined effect of in-
tra-CA1 injection of quinine, on amygdala-
kindled seizures. Furthermore, impact of 
Cx36 blockade on acquisition of kindled 
seizures (epileptogenesis) was also exam-
ined.  
 
MATERIALS AND METHODS 
Animals 
Male Wistar rats (270–320 g, Pasteur 
Institute of Iran) were used throughout this 
study. The animals were housed in standard 
Plexiglas cages with free access to food 
(standard laboratory rodent’s chow) and 
water. The animal house temperature was 
maintained at 23 ± 1 °C with a 12 h 
light/dark cycle (light on from 6.00 AM). 
Animal experiments protocol was approved 
by the Review Board and Ethics Committee 
of Pasteur Institute and conformed to Euro-
pean Communities Council Directive of 
November 1986 (86/609/EEC).  
 
Stereotaxic surgery and kindling  
procedure 
The rats were anesthetized with intra-
peritoneal (i.p.) injection of 60 mg/kg ket-
amine (Rotex Medica, Germany) and 
10 mg/kg xylazine (Candelle, Ireland). The 
animals were then stereotaxically implanted 
with bipolar stimulating and monopolar re-
cording stainless-steel Teflon-coated elec-
trodes (A.M. Systems, USA, twisted into a 
tripolar configuration), in the basolateral 
amygdala (coordinates: A, -2.5 mm from 
bregma; L, 4.8 mm from bregma and V, 
7.3 mm from dura) of the right hemisphere 
(Paxinos and Watson, 2005). An injection 
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guide-cannula was also implanted into the 
CA1 area of right hippocampus (coordi-
nates: A, −3.8; L, −2.3 and V, 2.4 mm from 
dura). The electrodes and cannula were 
fixed to the skull with dental acrylic. The 
animals were given 7 days for recovery af-
ter surgery, before the kindling protocol 
was started. One week after surgery, af-
terdischarge (AD) threshold was deter-
mined in amygdala by a 2-Sec, 100-Hz mo-
nophasic square-pulse stimulus of 1 mSec 
per pulse. The stimulation was initially de-
livered at 50 µA and then at 5-min inter-
vals, increasing stimulus intensity in incre-
ments of 50 µA was delivered, until at least 
5 Sec of AD was recorded (Beheshti et al., 
2010). Then, the animals were stimulated at 
AD threshold once daily until three consec-
utive stage 5 seizures were elicited accord-
ing to Racine classification as stage 1, faci-
al clonus; stage 2, head nodding; stage 3, 
forelimb clonus; stage 4, rearing and bilat-
eral forelimb clonus; stage 5, rearing, loss 
of balance and falling (Racine, 1972). 
These animals were then considered fully 
kindled. Quinine (hemisulfate salt monohy-
drate, Sigma-Aldrich) and artificial cere-
brospinal fluid (aCSF with composition (in 
mM) of 124.0 NaCl, 25 NaHCO3, 10 D-
glucose, 4.4 KCl, 2 MgSO4, 1.25 KH2PO4, 
and 2 CaCl2) were infused (1 µl in 5 min) 
into CA1 by a 27-gauge cannula, which 
was extended 1 mm below the tip of guide 
cannula.  
 
Effect of intra–CA1 injection of quinine 
on kindled seizures 
Quinine at doses of 1, 50, 100, 500, and 
2000 µM/rat was infused into CA1 of 5 
groups of kindled rats (n=7) and after 10 
and 30 min time intervals, amygdala was 
stimulated at AD threshold. This time point 
was selected based on previous report indi-
cating that peak effect of quinine appears 
10 min after cerebral application (Gajda et 
al., 2005). AD duration (ADD), behavioral 
seizure severity (SS), and duration of stage 
5 seizure behavior (S5D) were then meas-
ured in each animal. The animals served as 
their own control groups; i.e. the rats re-
ceived aCSF intra-CA1 24 h before quinine 
administration, and evoked seizure parame-
ters were recorded at above mentioned time 
intervals. 
 
Effect of intra–CA1 injection of quinine 
on kindling rate 
Twenty-four h after determination of 
AD threshold, the rats were divided into 
four groups of seven rats in each. They re-
ceived quinine (1, 30, and 100 µM/rat, in-
tra-CA1) or aCSF (1µl/rat, intra-CA1) once 
daily. Daily electrical stimulation was de-
livered 10 min before quinine or aCSF in-
jections until the animals became fully kin-
dled. SS and ADD were recorded after each 
stimulation.  
 
Histology 
At the end of the experiments, the 
brains were removed, processed, cut into 
50-µm thick slices and stained by the meth-
od previously described (Beheshti et al. 
2010). Stained slices were qualitatively 
analyzed for cannula and electrode posi-
tions and also any lesion, using a stereo-
scopic microscope (Olympus, Japan) and a 
light microscope (Zeiss, Germany). The 
data of the animals, in which the cannula 
and electrode were in false placement, were 
not included in the results. 
 
Statistical analysis 
Data are presented as mean ± SEM. If 
data had a normal distribution, they were 
analyzed by parametric test (ANOVA with 
repeated measures for post hoc analysis). 
Otherwise, the data were analyzed by non-
parametric test (Kruskal–Wallis analysis of 
variance). In all experiments, P < 0.05 was 
considered statistically significant. 
 
RESULTS 
The mean AD threshold obtained for the 
animals was in the range of 50–150 µA. 
Histological evaluation of the brains con-
firmed correct position of the electrode and 
cannula in all of the animals. 
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Quinine had no effect on fully kindled  
seizures 
Neither of the applied doses of quinine 
affected kindled seizure parameters at 10 
and 30 min post administration periods. 
Figures 1 and 2 show the results of 10 min 
post administration period.  
 
Quinine accelerates development of  
kindling 
All doses of quinine increased growth 
of AD during kindling development (Ta-
ble 1). Quinine 1 µM caused a 1.5 fold in-
crease in ADD at the time of focal seizures 
acquisition (behavioral seizure stage 2) 
compared to control group. Chronic admin-
istration of quinine 100 µM resulted in 1.5 
fold enhancement in ADD when the ani-
mals became fully kindled (showed stage 
5). Furthermore, at the dose of 100 µM the 
animals need lower number of stimuli to 
reach the kindled state. 
 
Figure 1: Effect of quinine on afterdischarges recorded from amygdala of a kindled rat 10 minutes 
after intra-CA1 administration 
 
 
 
aCSF 
Quinine 
Figure 2: Effect of quinine on kindled sei-
zures 10 minutes after intra-CA1 injection 
to rats. Values are mean ± SEM. 
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Table 1: Effects of daily intra-CA1 injection of quinine on development of kindling 
Number of  
stimuli needed 
to reach stage 5 
Number of  
stimuli needed  
to reach stage 2 
ADD on 
stage 5 
(Sec) 
ADD on  
stage 2 
(Sec) 
Initial ADD 
(Sec) 
Group 
16.6 ± 1.8 7.1 ± 1.1 42.8 ± 4.4 18.00 ± 2.7 6.6 ± 0.6 aCSF 
15.1 ± 1.2 7.3 ± 0.4 65.8 ± 5.3 30.6 ± 3.0 * 10.0 ± 0.6 Quinine (1 µM)  
18.1 ± 2.7 5.0 ± 0.2 62.5 ± 3.8 25.5 ± 3.1 8.43 ± 0.8 Quinine (30 µM) 
9.8 ± 0.8 * 6.0 ± 0.7 68.7 ± 9.1 * 27.1 ± 2.7 11.25 ± 1.0 Quinine (100 µM) 
Data represents mean ± SEM, (n=7). * p<0.05 compared to aCSF. aCSF: artificial cerebrospinal fluid; 
ADD: afterdischarge duration. Repeated treatment with quinine 1 and 100 µM significantly increased 
growth of AD during development of focal (behavioral seizure stage 2) and generalized (behavioral 
seizure stage 5) seizures. Quinine 100 µM was also capable to accelerate kindling rate, as quinine 
treated-animals required lower number of stimulations, compared to ACSF-treated animals, to develop 
generalized seizures (behavioral seizure stage 5).  
 
 
DISCUSSION 
Results of the present study indicate that 
blockade of GJs composed of Cx36 in the 
CA1 area of the rat hippocampus acceler-
ates progression of kindling but does not 
affect kindled seizures. 
Most in vivo studies on the effect of 
quinine on seizures have been performed in 
4-aminopyridine (4-AP) model of epilepsy 
(Gajda et al., 2005; Medina-Ceja and Ven-
tura-Mejía, 2010). The 4-AP model can be 
regarded as semi-chronic epilepsy model, 
as its specific feature is prolonged epilepti-
form activity in a manner that at least 25 
seizures occur spontaneously during a 60-
min period (Gajda et al., 2005). This speci-
ficity enables investigator to apply the in-
vestigating drug during seizures and ob-
serve the effect of drug on active state of 
GJs. In hyperexcitable conditions, confor-
mation of GJ channels changes to active 
state, and results in increase electrical 
communication between adjacent cells 
(Sáez et al., 2010). This might in turn cause 
more efficient binding of quinine to Cx36 
and therefore more functional blockade. 
However, in cases of acute seizures such as 
kindled seizures, duration of epileptic activ-
ity is not as long as that in 4-AP model. 
Therefore, quinine can not bind effectively 
to the Cx36. This assumption might be the 
reason of ineffectiveness of quinine on kin-
dled seizures. 
In our study, the rats which received 
quinine 100 µM, the dose which maximally 
blocks Cx36 GJs (Srinivas et al., 2001), de-
veloped generalized seizures much earlier 
than control rats. In the kindling model, the 
behavioral seizure stages 1, 2, and 3 most 
often originate from foci within the limbic 
system and are considered as focal seizures, 
while behavioral stages 4 and 5 represent 
secondary generalized motor seizures (Ra-
cine, 1972). Our finding suggests that Cx36 
GJs have a critical role in kindling epilep-
togenesis and inhibit seizure propagation 
from limbic focus to the rest of the brain 
and consequent generalizations of the sei-
zures. This result is in agreement with our 
previous finding that gene and protein of 
hippocampal Cx36 are over-expressed dur-
ing amygdala kindling (Beheshti et al., 
2010). 
Apart from hippocampus, Cx36 is also 
present in the mature cerebral cortex as the 
most common neuronal Cx, and its expres-
sion appears to be restricted almost exclu-
sively to a subclass of inhibitory interneu-
rons, parvalbumin-containing basket cells 
(Deans et al., 2001; Liu and Jones, 2003; 
Markram et al., 2004). Interestingly, block-
ing of cortical Cx36 GJs by quinine signifi-
cantly reinforces both the frequency and 
amplitude of seizure-like activity in rat cer-
ebral cortex (Voss et al., 2009). Closing 
Cx36 GJs and consequent disinhibitory ef-
fect on pyramidal cell activity is suggested 
to be involved in this proconvulsant effect 
of quinine. Moreover, it has been shown 
that knockout of Cx36 promotes epileptic 
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hyperexcitability (Pais et al., 2003) and de-
creases threshold of generalized tonic-
clonic seizures induced by PTZ (Jacobson 
et al., 2010). These results together with our 
finding in the present study confirm that 
Cx36 GJs, present in GABAergic interneu-
ron network, play a critical role in inhibito-
ry control of excitatory runaway activity 
(Jacobson et al., 2010). In contrast to these 
results, it has been reported that the block-
ade of Cx36 GJC attenuates seizures in 
some epilepsy models. Application of qui-
nine significantly decreases duration of the 
seizures induced by 4-AP (Gajda et al., 
2005). Quinine acts as an antiepileptic drug 
in penicillin model of cortical seizures 
(Bostanci and Bagirici, 2007). Moreover, 
quinine significantly decreases duration of 
PTZ-induced seizures in a dose-dependent 
manner (Nassiri-Asl et al., 2009). Likewise, 
injection of quinine into the entorhinal cor-
tex decreases amplitude and frequency of 
epileptic discharges in seizing rats (Medina-
Ceja and Ventura-Mejía, 2010). Two ex-
planations can be suggested for the para-
doxical effects of quinine on seizures; 1) 
Different models of seizures with different 
mechanisms of action have been used in 
these studies. For instance, in 4-AP model, 
blockade of K+ channels as well as gluta-
mate release, promote convulsions (Medi-
na-Ceja and Ventura-Mejía, 2010). Penicil-
lin induces seizures due to its similar struc-
ture to GABAA receptor antagonist bicucul-
line (Bostanci and Bagirci, 2007). On the 
other hand, Voss et a. (2009) induced sei-
zure-like activity by perfusion of cerebral 
cortical slices with low magnesium aCSF. 
In the present study, we used kindling mod-
el of epilepsy in which glutamatergic and 
GABAergic neurotransmission are involved 
in seizure manifestation. Therefore, it can 
be postulated that anticonvulsant or pro-
convulsant effect of quinine observed in the 
different studies, depends on the level of 
involvement of chemical or electrical syn-
apses in the particular epilepsy model used 
in each study. Here, we directly applied 
quinine into the CA1 area. CA1 pyramidal 
cells are involved in generalization of 
amygdala kindled seizures (Hewapathirane 
and Burnham, 2005). It seems that spread 
of activity within the inhibitory circuit in 
CA1 area is decreased by quinine, which in 
turn amplifies seizure propagation to out-
side of hippocampus. However, in other 
studies with opposite findings, the Cx36 
GJs present in inhibitory circuit, might not 
be affected in this manner. 2) In the reports 
regarding anticonvulsant effect of quinine, 
a wide range of doses has been used. Alt-
hough quinine is a specific blocker of Cx36 
GJ (EC50 = 32 µM, maximal blockade at 
100 µM) (Srinivas et al., 2001), it can also 
block Cx45 (EC50 = 300 µM), IP3-induced 
Ca2+ release (EC50 = 250 µM), Cx50 
(EC50 = 73 µM), Sodium currents (EC50> 
20 µM), voltage-dependent K+ channels 
(EC50 = 8 µM), ATP-sensitive K+ channels 
(EC50 = 3 µM) and nicotinic receptors 
(EC50 = 1 µM) (Juszczak and Swiergiel, 
2009). Therefore, the possibility exists that 
the anticonvulsant effect of quinine ob-
served in the other studies may be related to 
the off-target actions of this agent.  
It has recently been reported that long 
term potentiation (LTP) is reduced in the 
hippocampal CA1 region of Cx36 knockout 
mice (Wang and Belousov, 2011). Kindling 
is a model of epileptogenesis and synaptic 
plasticity, in which LTP of synaptic trans-
mission occurs (McNamara et al., 1980). 
According to our results, blocking Cx36 
GJs in CA1 region facilitates epileptogene-
sis and therefore LTP. Our finding appears 
to be in contrast to finding of Wang and 
Belousov (2011). However, it has been well 
documented that Cx36 knockout mice have 
an increased GABAergic tone as a compen-
sation for their lack of interneuron GJs, 
which results in enhancement of feedback 
inhibition (De Zeeuw et al., 2003; Cum-
mings et al., 2008; Voss et al., 2010a). 
Hence, reduction of hippocampal LTP in 
mice lacking Cx36 might not be necessarily 
mediated by lack of interneuronal GJs, ra-
ther by compensatory overactivity of GA-
BAergic interneurons.  
In conclusion, we found that chronic in-
tra-CA1 injection of quinine, at the dose of 
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100 µM, which specifically blocks Cx36 
GJs, facilitates epileptogenesis by accelera-
tion of kindling development. Cx36 can be 
considered as a molecular target in preven-
tion of epilepsy. Due to possible confusing 
effect made by compensatory neurophysio-
logical changes in knockout animals, design 
and availability of specific Cx36 GJ open-
ers are needed to further clarify Cx36 GJs 
potential for antiepileptic drugs develop-
ment. 
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